CN104755102A - 多价肺炎球菌多糖-蛋白质结合物组合物 - Google Patents
多价肺炎球菌多糖-蛋白质结合物组合物 Download PDFInfo
- Publication number
- CN104755102A CN104755102A CN201380044326.8A CN201380044326A CN104755102A CN 104755102 A CN104755102 A CN 104755102A CN 201380044326 A CN201380044326 A CN 201380044326A CN 104755102 A CN104755102 A CN 104755102A
- Authority
- CN
- China
- Prior art keywords
- serotype
- immunogenic composition
- polysaccharide
- adjuvant
- multivalent immunogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
血清型 | Prevnar 13 | SK-15 | 血清型 | Prevnar 13 | SK-15 |
1 | 1:16 | 1:4 | 9V | 1:256 | 1:256 |
2 | - | 1:128 | 9N | - | 1:512 |
3 | 不稀释 | 不稀释 | 14 | 1:256 | 1:256 |
4 | 1:128 | 1:128 | 18C | 1:1024 | 1:1024 |
5 | 1:64 | 1:32 | 19A | 1:512 | 1:256 |
6A | 1:512 | 1:256 | 19F | 1:256 | 1:128 |
6B | 1:256 | 1:128 | 23F | 1:256 | 1:256 |
7F | 1:1024 | 1:1024 | - | - | - |
血清型 | Prevnar13 | SK-15 | 血清型 | Prevnar 13 | SK-15 |
1 | 1:64 | 1:64 | 9V | 1:512 | 1:512 |
2 | - | 1:512 | 9N | - | 1:2048 |
3 | 1:2 | 1:4 | 14 | 1:1024 | 1:1024 |
4 | 1:1024 | 1:1024 | 18C | 1:1024 | 1:512 |
5 | 1:256 | 1:256 | 19A | 1:1024 | 1:1024 |
6A | 1:2048 | 1:2048 | 19F | 1:1024 | 1:512 |
6B | 1:2048 | 1:2048 | 23F | 1:2048 | 1:2048 |
7F | 1:2048 | 1:2048 | - | - | - |
血清型 | Prevnar 13 | SK-15 | 血清型 | Prevnar 13 | SK-15 |
1 | 1:64 | 1:64 | 9V | 1:512 | 1:512 |
2 | - | 1:512 | 9N | - | 1:2048 |
3 | 1:4 | 1:4 | 14 | 1:1024 | 1:1024 |
4 | 1:1024 | 1:1024 | 18C | 1:2048 | 1:2048 |
5 | 1:512 | 1:512 | 19A | 1:2048 | 1:1024 |
6A | 1:2048 | 1:2048 | 19F | 1:1024 | 1:512 |
6B | 1:2048 | 1:1024 | 23F | 1:2048 | 1:2048 |
7F | 1:2048 | 1:2048 | - | - | - |
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120065893A KR102057217B1 (ko) | 2012-06-20 | 2012-06-20 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
KR10-2012-0065893 | 2012-06-20 | ||
PCT/KR2013/005392 WO2013191459A1 (ko) | 2012-06-20 | 2013-06-19 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104755102A true CN104755102A (zh) | 2015-07-01 |
CN104755102B CN104755102B (zh) | 2018-01-23 |
Family
ID=49768999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380044326.8A Active CN104755102B (zh) | 2012-06-20 | 2013-06-19 | 多价肺炎球菌多糖‑蛋白质结合物组合物 |
Country Status (14)
Country | Link |
---|---|
US (2) | US10034949B2 (zh) |
EP (1) | EP2865392B2 (zh) |
JP (1) | JP2015520227A (zh) |
KR (1) | KR102057217B1 (zh) |
CN (1) | CN104755102B (zh) |
AU (1) | AU2013278145B2 (zh) |
BR (1) | BR112014032091B1 (zh) |
CA (1) | CA2877648C (zh) |
CO (1) | CO7240387A2 (zh) |
ES (1) | ES2613720T5 (zh) |
MX (1) | MX358977B (zh) |
PH (1) | PH12014502843B1 (zh) |
RU (1) | RU2605834C2 (zh) |
WO (1) | WO2013191459A1 (zh) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150061019A (ko) | 2005-04-08 | 2015-06-03 | 와이어쓰 엘엘씨 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
KR102057217B1 (ko) * | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
EP4286000A3 (en) * | 2014-01-21 | 2024-02-14 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
KR102049826B1 (ko) | 2014-01-21 | 2019-12-03 | 화이자 인코포레이티드 | 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체 |
US11160855B2 (en) * | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
HRP20230416T1 (hr) | 2015-01-15 | 2023-07-07 | Pfizer Inc. | Imunogeni pripravci, namijenjeni upotrebi u cjepivima protiv pneumokoka |
PE20180172A1 (es) | 2015-05-04 | 2018-01-22 | Pfizer | Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos |
MY187461A (en) * | 2015-06-08 | 2021-09-23 | Serum Inst Of India Private Ltd | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof |
HUE053272T2 (hu) | 2015-06-23 | 2021-06-28 | Biological E Ltd | Multivalens konjugált pneumococcus vakcina |
CN108367063A (zh) * | 2015-07-21 | 2018-08-03 | 辉瑞公司 | 包含缀合的荚膜糖抗原的免疫原性组合物及其试剂盒和用途 |
JP7164200B2 (ja) | 2016-03-31 | 2022-11-01 | ポゴナ, エルエルシー | サッカライド-ポリペプチドコンジュゲートの組成物およびその使用の方法 |
BR112019001971A2 (pt) | 2016-08-05 | 2019-05-07 | Sanofi Pasteur, Inc. | composição conjugada de polissacarídeo-proteína pneumocócica multivalente |
EP3493840B1 (en) | 2016-08-05 | 2022-08-24 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
JOP20190038B1 (ar) * | 2016-09-06 | 2023-09-17 | Lg Chemical Ltd | تركيب اقتراني من السكر المتعدد لكبسولة بكتيريا المكورات الرئوية وبروتين حامل واستخداماته |
EP3518965A1 (en) * | 2016-09-30 | 2019-08-07 | Biological E Limited | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
WO2018080213A1 (ko) * | 2016-10-28 | 2018-05-03 | 주식회사 엘지화학 | 향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도 |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
WO2018156491A1 (en) * | 2017-02-24 | 2018-08-30 | Merck Sharp & Dohme Corp. | Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates |
MX2020002556A (es) | 2017-09-07 | 2020-07-13 | Merck Sharp & Dohme | Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora. |
US11395849B2 (en) | 2017-09-07 | 2022-07-26 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
CN111683678B (zh) | 2017-12-06 | 2024-01-26 | 默沙东有限责任公司 | 包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法 |
WO2019152921A1 (en) | 2018-02-05 | 2019-08-08 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
KR102486891B1 (ko) | 2018-02-05 | 2023-01-10 | 사노피 파스퇴르 인코포레이티드 | 다가 폐렴구균성 다당류-단백질 접합체 조성물 |
CA3096358A1 (en) * | 2018-04-18 | 2019-10-24 | Sk Bioscience Co., Ltd. | Streptococcus pneumoniae capsular polysaccharide and immunogenic conjugate thereof |
TWI788610B (zh) | 2018-12-19 | 2023-01-01 | 美商默沙東有限責任公司 | 包含肺炎鏈球菌多醣-蛋白質結合物之組合物及其使用方法 |
KR20200136756A (ko) * | 2019-05-28 | 2020-12-08 | 에스케이바이오사이언스(주) | 스트렙토코커스 뉴모니애 혈청형 23f의 면역원성 접합체 제조방법 |
AU2020323498A1 (en) | 2019-07-31 | 2022-03-03 | Sk Bioscience Co., Ltd. | Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same |
US20210070890A1 (en) * | 2019-09-06 | 2021-03-11 | Serum Institute Of India Private Limited | Method for obtaining purified bacterial polysaccharides |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1566145A (zh) * | 2003-07-04 | 2005-01-19 | 上海健益科技发展有限公司 | 多价肺炎球菌多糖结合疫苗 |
CN101590224A (zh) * | 2009-06-30 | 2009-12-02 | 广州精达医学科技有限公司 | 高效14价肺炎球菌结合疫苗 |
CN101972475A (zh) * | 2010-04-12 | 2011-02-16 | 李建平 | 一种细菌多糖-蛋白结合疫苗及其制备方法 |
WO2011100151A1 (en) * | 2010-02-09 | 2011-08-18 | Merck Sharp & Dohme Corp. | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
CA2059693C (en) | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
US5769047A (en) | 1991-12-23 | 1998-06-23 | Zoche; Michael | Engine with oil separator |
DK0616034T3 (da) | 1993-03-05 | 2005-02-21 | Wyeth Corp | Plasmid til fremstilling af CRM-protein og diphtheria toxin |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
DE69937571T2 (de) | 1998-09-30 | 2008-09-04 | The Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences | Mutiertes cholera holotoxin als hilfsmittel |
PL203917B1 (pl) | 1999-03-19 | 2009-11-30 | Glaxosmithkline Biolog Sa | Kompozycja immunogenna, sposób jej wytwarzania oraz zastosowanie |
FR2806304B1 (fr) | 2000-03-17 | 2002-05-10 | Aventis Pasteur | Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie |
GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
AU2002227450B2 (en) | 2000-12-28 | 2008-02-28 | Wyeth | Recombinant protective protein from $I(streptococcus pneumoniae) |
WO2002083855A2 (en) | 2001-04-16 | 2002-10-24 | Wyeth Holdings Corporation | Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
IL159209A0 (en) | 2001-06-07 | 2004-06-01 | Wyeth Corp | Mutant forms of cholera holotoxin as an adjuvant |
AU2002346249B2 (en) | 2001-06-07 | 2007-03-15 | The Regents Of The University Of Colorado | Mutant Forms of Cholera Holotoxin as an Adjuvant |
WO2004083251A2 (en) | 2003-03-17 | 2004-09-30 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
GB0409745D0 (en) | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
JP4079925B2 (ja) | 2004-08-09 | 2008-04-23 | Necアクセステクニカ株式会社 | 無線機 |
GB0502095D0 (en) * | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
KR20150061019A (ko) * | 2005-04-08 | 2015-06-03 | 와이어쓰 엘엘씨 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
CA2611960C (en) * | 2005-06-27 | 2015-05-05 | Glaxosmithkline Biologicals S.A. | Immunogenic compositions comprising n.meningitidis capsular saccharide conjugates |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
AR058707A1 (es) | 2005-12-22 | 2008-02-20 | Glaxosmithkline Biolog Sa | Vacuna, procedimiento para fabricarla y su uso |
EA200901578A1 (ru) | 2007-06-26 | 2010-08-30 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae |
GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
KR101450958B1 (ko) | 2009-04-30 | 2014-10-15 | 콜레이 파마시티컬 그룹, 인코포레이티드 | 폐렴구균 백신 및 그의 용도 |
DE102009035739A1 (de) | 2009-08-01 | 2011-02-03 | Schaeffler Technologies Gmbh & Co. Kg | Dichtungseinrichtung für ein Drehlager |
HUE048398T2 (hu) | 2010-06-04 | 2020-07-28 | Wyeth Llc | Vakcinakészítmények |
MX2013006539A (es) | 2010-12-10 | 2013-07-22 | Merck Sharp & Dohme | Formulaciones novedosas que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas. |
KR102057217B1 (ko) * | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
-
2012
- 2012-06-20 KR KR1020120065893A patent/KR102057217B1/ko active IP Right Grant
-
2013
- 2013-06-19 WO PCT/KR2013/005392 patent/WO2013191459A1/ko active Application Filing
- 2013-06-19 MX MX2014016065A patent/MX358977B/es active IP Right Grant
- 2013-06-19 BR BR112014032091-8A patent/BR112014032091B1/pt active IP Right Grant
- 2013-06-19 EP EP13806263.3A patent/EP2865392B2/en active Active
- 2013-06-19 RU RU2015100140/15A patent/RU2605834C2/ru active
- 2013-06-19 AU AU2013278145A patent/AU2013278145B2/en active Active
- 2013-06-19 US US14/409,865 patent/US10034949B2/en active Active
- 2013-06-19 ES ES13806263T patent/ES2613720T5/es active Active
- 2013-06-19 CN CN201380044326.8A patent/CN104755102B/zh active Active
- 2013-06-19 JP JP2015518332A patent/JP2015520227A/ja active Pending
- 2013-06-19 CA CA2877648A patent/CA2877648C/en active Active
-
2014
- 2014-12-19 PH PH12014502843A patent/PH12014502843B1/en unknown
-
2015
- 2015-01-19 CO CO15009517A patent/CO7240387A2/es unknown
-
2017
- 2017-05-02 US US15/584,525 patent/US10058607B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1566145A (zh) * | 2003-07-04 | 2005-01-19 | 上海健益科技发展有限公司 | 多价肺炎球菌多糖结合疫苗 |
CN101590224A (zh) * | 2009-06-30 | 2009-12-02 | 广州精达医学科技有限公司 | 高效14价肺炎球菌结合疫苗 |
WO2011100151A1 (en) * | 2010-02-09 | 2011-08-18 | Merck Sharp & Dohme Corp. | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
CN101972475A (zh) * | 2010-04-12 | 2011-02-16 | 李建平 | 一种细菌多糖-蛋白结合疫苗及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2865392B2 (en) | 2020-02-12 |
RU2015100140A (ru) | 2016-08-10 |
KR102057217B1 (ko) | 2020-01-22 |
EP2865392A4 (en) | 2016-01-20 |
EP2865392A1 (en) | 2015-04-29 |
CO7240387A2 (es) | 2015-04-17 |
CN104755102B (zh) | 2018-01-23 |
MX358977B (es) | 2018-09-11 |
BR112014032091A8 (pt) | 2018-07-31 |
EP2865392B1 (en) | 2016-11-16 |
MX2014016065A (es) | 2015-10-09 |
RU2605834C2 (ru) | 2016-12-27 |
US20170232101A1 (en) | 2017-08-17 |
KR20130142574A (ko) | 2013-12-30 |
JP2015520227A (ja) | 2015-07-16 |
US10034949B2 (en) | 2018-07-31 |
ES2613720T5 (es) | 2020-07-09 |
US20150190520A1 (en) | 2015-07-09 |
CA2877648C (en) | 2016-08-23 |
AU2013278145B2 (en) | 2016-04-21 |
AU2013278145A1 (en) | 2015-02-05 |
ES2613720T3 (es) | 2017-05-25 |
US10058607B2 (en) | 2018-08-28 |
BR112014032091A2 (pt) | 2017-10-10 |
BR112014032091B1 (pt) | 2022-07-26 |
CA2877648A1 (en) | 2013-12-27 |
PH12014502843A1 (en) | 2015-02-09 |
PH12014502843B1 (en) | 2015-02-09 |
WO2013191459A1 (ko) | 2013-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104755102B (zh) | 多价肺炎球菌多糖‑蛋白质结合物组合物 | |
CN104837505A (zh) | 多价肺炎球菌多糖-蛋白结合组合物 | |
CN104837504A (zh) | 多价肺炎球菌多糖-蛋白结合组合物 | |
CN102858365A (zh) | 15价肺炎球菌多糖蛋白质缀合物疫苗组合物 | |
KR20150061020A (ko) | 다가 폐렴구균 다당류-단백질 접합체 조성물 | |
KR20220017996A (ko) | 면역원성 혈청형 35b 폐렴구균 폴리사카라이드-단백질 접합체 및 그를 제조하기 위한 접합 방법 | |
CN110520154A (zh) | 多价肺炎链球菌疫苗组合物 | |
KR20180027353A (ko) | 다가 협막 다당류-운반 단백질을 포함하는 조성물 및 이의 용도 | |
KR102083973B1 (ko) | 향상된 IgG 역가를 갖는 다가면역원성 조성물 및 이의 용도 | |
TWI586363B (zh) | 多價肺炎球菌多醣-蛋白質共軛物組成物 | |
EA041147B1 (ru) | Композиция многовалентных пневмококковых конъюгатов капсульного полисахарида с белком-носителем и ее применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Gyeonggi Do, South Korea Patentee after: SK discovery Co. Address before: Gyeonggi Do, South Korea Patentee before: SK CHEMICALS Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180607 Address after: Gyeonggi Do, South Korea Patentee after: SK CHEMICALS Co.,Ltd. Address before: Gyeonggi Do, South Korea Patentee before: SK discovery Co. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181114 Address after: Gyeonggi Do, South Korea Patentee after: SK BIOSCIENCE Co.,Ltd. Address before: Gyeonggi Do, South Korea Patentee before: SK CHEMICALS Co.,Ltd. |
|
TR01 | Transfer of patent right |